NCT07064967 Non-Helium Magnetoencephalography in Autism Spectrum Disorder
| NCT ID | NCT07064967 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Guangzhou Women and Children's Medical Center |
| Condition | Autism Spectrum Disorder (ASD) |
| Study Type | OBSERVATIONAL |
| Enrollment | 80 participants |
| Start Date | 2024-11-05 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 80 participants in total. It began in 2024-11-05 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to learn how brain activity in children with autism spectrum disorder (ASD) differs from typical developing children using magnetoencephalography (MEG). The main questions this study aims to answer are: Do children with ASD show different patterns of neural oscillation compared to typically developing children? Can MEG identify specific brain features that help ASD diagnosis? Participants will undergo MEG scan in both resting and tasking state, and their brain activity will be analyzed for characteristic neural oscillations and connectivity patterns. This study may help develop better tools for early ASD diagnosis.
Eligibility Criteria
Inclusion Criteria: * Boys aged 6 to 12 years; * Diagnosis of Autism Spectrum Disorder meeting DSM-5 criteria; * Intelligence quotient (IQ) score \> 70 (assessed via Wechsler Intelligence Scale for Children or other validated cognitive test); * Sufficient compliance to participate in MEG experiments. Exclusion Criteria: * Comorbid neurological disorders, genetic syndromes, or severe developmental disabilities; * Metallic implants that may interfere with MEG signal acquisition; * Current use of antipsychotic medications or sedatives.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07064967 clinical trial?
This trial is open to male participants only, aged 6 Years or older, up to 12 Years, studying Autism Spectrum Disorder (ASD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07064967 currently recruiting?
Yes, NCT07064967 is actively recruiting participants. Contact the research team at 15625984282@163.com for enrollment information.
Where is the NCT07064967 trial being conducted?
This trial is being conducted at Guangzhou, China.
Who is sponsoring the NCT07064967 clinical trial?
NCT07064967 is sponsored by Guangzhou Women and Children's Medical Center. The trial plans to enroll 80 participants.